Back
4D Molecular Therapeutics Stock Price Chart
Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!
Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)
Buy
51
FDMT
4D Molecular Therapeutics
Last Price:
6.90
Seasonality Move:
19.19%
7 Day Trial
ALL ACCESS PASS
$
7
Better Than Oil Stocks
CLICK HERE TO FIND OUT MORE- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FDMT is experiencing slight buying pressure.
4D Molecular Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 7.28 | Sell |
| 20-day SMA: | 7.74 | Sell |
| 50-day SMA: | 8.39 | Sell |
| 200-day SMA: | 18.93 | Sell |
| 8-day EMA: | 7.31 | Sell |
| 20-day EMA: | 7.67 | Sell |
| 50-day EMA: | 9.04 | Sell |
| 200-day EMA: | 15.11 | Sell |
4D Molecular Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.45 | Sell |
| Relative Strength Index (14 RSI): | 40.08 | Sell |
| Chaikin Money Flow: | 216927 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.33 - 8.35) | Sell |
| Bollinger Bands (100): | (8.1 - 15.48) | Sell |
4D Molecular Therapeutics Technical Analysis
| Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 26 | 27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for 4D Molecular Therapeutics Stock
Is 4D Molecular Therapeutics Stock a Buy?
- 4D Molecular Therapeutics share price is 7.24 while FDMT 8-day simple moving average is 7.28, which is a Sell signal.
- The stock price of FDMT is 7.24 while 4D Molecular Therapeutics 20-day SMA is 7.74, which makes it a Sell.
- 4D Molecular Therapeutics 50-day simple moving average is 8.39 while FDMT share price is 7.24, making it a Sell technically.
- FDMT stock price is 7.24 and 4D Molecular Therapeutics 200-day simple moving average is 18.93, creating a Sell signal.
FDMT Technical Analysis vs Fundamental Analysis
Buy
51
4D Molecular Therapeutics (FDMT)
is a Buy
Is 4D Molecular Therapeutics a Buy or a Sell?
-
4D Molecular Therapeutics stock is rated a Buy
The current 4D Molecular Therapeutics [FDMT] share price is $7.24. The Score for FDMT is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
4D Molecular Therapeutics Stock Info
Market Cap:
334.69M
Price in USD:
7.24
Share Volume:
460.97K
4D Molecular Therapeutics 52-Week Range
52-Week High:
36.25
52-Week Low:
6.77
Buy
51
4D Molecular Therapeutics (FDMT)
is a Buy
4D Molecular Therapeutics Share Price Forecast
-
What is the 4D Molecular Therapeutics stock price today?
The 4D Molecular Therapeutics stock price is 7.24 USD today. -
Will FDMT stock go up or go down?
4D Molecular Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is 4D Molecular Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, 4D Molecular Therapeutics is not overvalued.
Is 4D Molecular Therapeutics Stock a Buy?
- 4D Molecular Therapeutics share price is 7.24 while FDMT 8-day exponential moving average is 7.31, which is a Sell signal.
- The stock price of FDMT is 7.24 while 4D Molecular Therapeutics 20-day EMA is 7.67, which makes it a Sell.
- 4D Molecular Therapeutics 50-day exponential moving average is 9.04 while FDMT share price is 7.24, making it a Sell technically.
- FDMT stock price is 7.24 and 4D Molecular Therapeutics 200-day simple moving average is 15.11, creating a Sell signal.
Fundamental Analysis of 4D Molecular Therapeutics
Is 4D Molecular Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.36 per share, and a decrease next year of $0.69 per share.
Technical Analysis of 4D Molecular Therapeutics
Should I short 4D Molecular Therapeutics stock?
- FDMT Moving Average Covergence Divergence (MACD) indicator is -0.45, suggesting 4D Molecular Therapeutics is a Sell
- 4D Molecular Therapeutics Relative Strength Index (RSI) is 40.08, which suggest 4D Molecular Therapeutics is oversold
- The Bollinger Bands (25) for 4D Molecular Therapeutics is (7.33 - 8.35), which suggest 4D Molecular Therapeutics is a Sell
- The Bollinger Bands (100) for 4D Molecular Therapeutics is (8.1 - 15.48), which suggest 4D Molecular Therapeutics is a Sell
* 4D Molecular Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.